Validation of the Dutch Version of the Brief Negative Symptom Scale

Código QR

Validation of the Dutch Version of the Brief Negative Symptom Scale

Birgit L Seelen-de Lang,1 Christien E Boumans,2 Henk LI Nijman3 1Flexible Assertive Community Treatment-Team, GGZ Oost Brabant, Boekel, the Netherlands; 2Long-Term Clinical Care, GGZ Oost Brabant, Boekel, the Netherlands; 3Behavioural Science Institute, Radboud University, Nijmegen, the NetherlandsC...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Seelen-de Lang BL, Boumans CE, Nijman HLI
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	bnss dutch translation negative symptoms schizophrenia validation Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/648ce46c04ff49689061a5892b815efd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Validation of the Chinese Version of the 16-Item Negative Symptom Assessment
por: Huang B, et al.
Publicado: (2020)

Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS)
por: Hashimoto N, et al.
Publicado: (2019)

Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment
por: Aleksandr M. Reznik, et al.
Publicado: (2020)

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
por: Octavian Vasiliu
Publicado: (2021)

Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits
por: Lijuan Huo, et al.
Publicado: (2021)

Measuring negative symptoms in patients with schizophrenia: reliability and validity of the Korean version of the Motivation and Pleasure Scale-Self-Report
por: Kim JS, et al.
Publicado: (2016)

Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study
por: Liang Y, et al.
Publicado: (2017)

Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
por: Correll CU, et al.
Publicado: (2020)

Online Left-Hemispheric In-Phase Frontoparietal Theta tACS for the Treatment of Negative Symptoms of Schizophrenia
por: Chuan-Chia Chang, et al.
Publicado: (2021)

Cognitive dysfunction and negative symptoms in patients with schizophrenia and their first-degree relatives from simplex and multiplex families
por: Zhang Z, et al.
Publicado: (2018)

Irregularity indices for line graph of Dutch windmill graph
por: Mohammed,Mohanad A., et al.
Publicado: (2020)

The Effects of Recreation Therapy on the Habit of Smoking and Positive–Negative Symptoms Among Patients with Chronic Schizophrenia
por: Pirbalouti M. G., et al.
Publicado: (2017)

Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia
por: Wang LJ, et al.
Publicado: (2016)

Cariprazine: Patients with Treatment-Resistant Schizophrenia
por: Aubel T
Publicado: (2021)

Influence of CFH gene on symptom severity of schizophrenia
por: Zhang C, et al.
Publicado: (2017)

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
por: Zhuo K, et al.
Publicado: (2019)

Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial
por: Somaieh Ashrafi, et al.
Publicado: (2022)

Decline in Psychotic Symptoms in Addition to Cardiac and Metabolic Safety with Cariprazine After Poor Response to Previous Antipsychotic Treatments – A Series of Two Cases
por: Müller HHO, et al.
Publicado: (2021)

Linguistic Validation of the Canine Brief Pain Inventory (CBPI) for Global Use
por: Jane R. Wells, et al.
Publicado: (2021)

The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia
por: Urban-Kowalczyk M, et al.
Publicado: (2021)

Practical clinical tool to monitor dementia symptoms: the HABC-Monitor
por: Monahan PO, et al.
Publicado: (2012)

Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience
por: Montes JM, et al.
Publicado: (2021)

The Healthy Aging Brain Care (HABC) Monitor: validation of the Patient Self-Report Version of the clinical tool designed to measure and monitor cognitive, functional, and psychological health
por: Monahan PO, et al.
Publicado: (2014)

Highly Suspected COVID-19 Cluster with Multiple Negative SARS-CoV-2 RNA Tests: A Case Report
por: Huang X, et al.
Publicado: (2021)

Relationship between social and cognitive functions in people with schizophrenia
por: Tominaga T, et al.
Publicado: (2018)

Schizophrenia and toxoplasmosis: association with catatonic symptoms
por: Dmitry V. Romanov, et al.
Publicado: (2020)

Associations between the mismatch-negativity component and symptom severity in children and adolescents with attention deficit/hyperactivity disorder
por: Yamamuro K, et al.
Publicado: (2016)

Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia
por: Urban-Kowalczyk M, et al.
Publicado: (2016)

Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
por: Suguru Nakajima, et al.
Publicado: (2021)

Metacognitive Beliefs, Cognitive Functioning, Psychiatric Symptoms and Empathy in People with Schizophrenia
por: Chuang SP, et al.
Publicado: (2021)

Regulating the use of genetic tests: Is Dutch law an example for other countries with regard to DTC genetic testing?
por: R.E. van Hellemondt, et al.
Publicado: (2011)

Functional and Facilitating: A Look into the Promotion and Standardization of Dutch as the Official Language in the Netherlands
por: Zhang Jiachen
Publicado: (2021)

Suicidality, self-stigma, social anxiety and personality traits in stabilized schizophrenia patients – a cross-sectional study
por: Vrbova K, et al.
Publicado: (2018)

Vietnamese Version of the General Medication Adherence Scale (GMAS): Translation, Adaptation, and Validation
por: Thao Huong Nguyen, et al.
Publicado: (2021)

Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study
por: Gopal S, et al.
Publicado: (2020)

Reviews: The Family and the Nation. Dutch Family Migration Policies in the Context of Changing Family Norms
por: Betty de Hart
Publicado: (2008)

Psychometric Validation of the Dutch Version of the Promotive and Prohibitive Voice Scale
por: Roy B. L. Sijbom, et al.
Publicado: (2021)

Short-term functional outcome in psychotic patients: results of the Turku early psychosis study (TEPS)
por: Raimo K. R. Salokangas, et al.
Publicado: (2021)

Relationship Between Cognitive and Clinical Insight at Different Durations of Untreated Attentional Psychotic Symptoms in High-Risk Individuals
por: LiHua Xu, et al.
Publicado: (2021)

Co można zrobić ze strachu?
por: Marek Piela
Publicado: (2020)